Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Phase 2 HORIZON Study of Melflufen in Relapsed/Refractory Multiple Myeloma Refractory to Daratumumab and/or Pomalidomide: Updated Efficacy and Safety

202 views
November 18, 2019
Comments 0
Login to view comments. Click here to Login